ScholarIQanswers from OpenAlex & ORCID
Willem J. Remme
ResearcherPublications, citations & collaboration network
Willem J. Remme is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Willem J. Remme have?
ScholarIQindexed works
Willem J. Remme has 230 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Willem J. Remme have?
ScholarIQcitation count
Willem J. Remme has 29,536 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Willem J. Remme?
ScholarIQh-index
Willem J. Remme has an h-index of 48 in OpenAlex.
What is the i10-index of Willem J. Remme?
ScholarIQi10-index
Willem J. Remme has an i10-index of 109 in OpenAlex.
What is the OpenAlex record for Willem J. Remme?
ScholarIQopenalex
The OpenAlex for Willem J. Remme is on the source record.
What are the most-cited papers on Willem J. Remme?
ScholarIQmost cited works
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Bertram Pitt, Faı̈ez Zannad, Willem J. Remme, Robert Cody, A Castaigne, A.J. Pérez Pérez, Jolie Palensky, Janet Wittes
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
Bertram Pitt, Willem J. Remme, Faı̈ez Zannad, James D. Neaton, Felipe A. Martínez, Barbara Roniker, Richard M. Bittman, Steve Hurley, Jay H. Kleiman, Marjorie Gatlin
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Bertram Pitt, Faı̈ez Zannad, Willem J. Remme, Robert Cody, A Castaigne, A.J. Pérez Pérez, Jolie Palensky, Janet Wittes
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
Karl Swedberg, John G.F. Cleland, Henry Dargie, Helmut Drexler, Ferenc Folláth, Michel Komajda, Luigi Tavazzi, Otto A. Smiseth, Antonello Gavazzi, Axel Haverich, Arno W. Hoes, Tiny Jaarsma, J Korewicki, Samuel Lévy, Cecilia Linde, J L López-Sendón, Markku S. Nieminen, Luc Piérard, Willem J. Remme
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial
Philip A. Poole‐Wilson, Karl Swedberg, John G.F. Cleland, Andrea Di Lenarda, Peter Hanrath, Michel Komajda, Jacobus Lubsen, Beatrix Lutiger, Marco Metra, Willem J. Remme, Christian Torp‐Pedersen, Armin Scherhag, Allan M. Skene